Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Tatsi Fecal Samples Metabolomics

ABSTRACT: Untargeted LC/MS metabolomics of stool samples collected as part of Microbiome Core.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter C Dorrestein

PROVIDER: MSV000091419 | GNPS | Mon Mar 06 14:30:00 GMT 2023

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - Asthma Cohort Fecal Samples Metabolomics

Project description:Untargeted LC/MS metabolomics of stool samples for Asthma cohort collected as part of the Microbiome Core.

2023-03-06 | MSV000091420 | GNPS

Altered fecal small RNA profiles in colorectal cancer reflect gut microbiome composition in stool samples

Project description:Dysbiotic configurations of the human gut microbiota have been linked with colorectal cancer (CRC). Human small non-coding RNAs are also implicated in CRC and recent findings suggest that their release in the gut lumen contributes to shape the gut microbiota. Bacterial small RNAs (bsRNAs) may also play a role in carcinogenesis but their role is less explored. Here, we performed small RNA and shotgun sequencing on 80 stool specimens of patients with CRC, or adenomas, and healthy subjects collected in a cross-sectional study to evaluate their combined use as a predictive tool for disease detection. We reported a considerable overlap and correlation between metagenomic and bsRNA quantitative taxonomic profiles obtained from the two approaches. Furthermore, we identified a combined predictive signature composed by 32 features from human and microbial small RNAs and DNA-based microbiome able to accurately classify CRC from healthy and adenoma samples (AUC= 0.87). In summary we reported evidence that host-microbiome dysbiosis in CRC can be observed also by altered small RNA stool profiles. Integrated analyses of the microbiome and small RNAs in the human stool may provide insights for designing more accurate tools for diagnostic purposes.

2019-08-30 | GSE132236 | GEO

GNPS - Asthma Cohort Blood Samples Rerun Metabolomics

Project description:Untargeted LC/MS (re-run on Q-exactive Mass Spectrometer) metabolomics of blood samples for Asthma cohort collected as part of the Microbiome Core.

2023-03-06 | MSV000091421 | GNPS

GNPS - CMI - MAP Stool Samples

Project description:MAP Stool samples for Microbiome Core - CMI. Human stool samples analyzed via untargeted metabolomics (LC/MS) using Thermo Q-Exactive and Polar C18 column. Positive polarity acquisition of LC-MS/MS.

2022-10-12 | MSV000090521 | GNPS

GNPS - CMI - Sharpton whole stool samples

Project description:Sharpton whole stool samples for Microbiome Core - CMI. Human stool samples analyzed via untargeted metabolomics (LC/MS) using Thermo Q-Exactive and Polar C18 column. Positive polarity acquisition of LC-MS/MS.

2022-10-12 | MSV000090525 | GNPS

Fecal metatranscriptomics from healthy adults before and after supplementation with bovine milk oligosaccharides

Project description:Complex oligosaccharides found in human milk play a vital role in gut microbiome development for the human infant. Bovine milk oligosaccharides (BMO) have similar structures with those derived from human milk, but have not been well studied for their effects on the healthy adult human gut microbiome. Healthy human subjects consumed BMO over two-week periods at two different doses and provided fecal samples. Metatranscriptomics of fecal samples was conducted to determine microbial and host gene expression in response to the supplement. Fecal samples were also analyzed by mass spectrometry to determine levels of undigested BMO. No changes were observed in microbiome activity across all participants. Repeated sampling enabled subject-specific analyses: four of six participants had minor, yet statistically significant, changes in microbial activity. No significant change was observed in the gene expression of host cells in stool. Levels of BMO excreted in feces after supplementation were not significantly different from placebo and were not correlated with dosage or expressed microbial enzyme levels. Collectively, these data suggest that BMO is fully digested in the human gastrointestinal tract prior to stool collection. Participants’ gut microbiomes remained stable but varied between individuals. Additionally, the unaltered host transcriptome provides further evidence for the safety of BMO as a dietary supplement or food ingredient.

2020-02-18 | GSE108809 | GEO

Tibetan sheep microbiome and metabolomics

Project description:Tibetan sheep microbiome and metabolomics

| PRJEB36249 | ENA

Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population

Project description:Many previous studies had revealed that gastrointestinal microbiome is changed compositionally and ecologically in patients with colorectal cancer comparing with healthy population. These finding provide us with a new sight to take advantage of gut microbiota. The current study aims to explore new potential biomarkers for early screening and prognostic prediction of colorectal cancer and colorectal polyps by analyzing metagenomics and metabolomics of gut microbiota.

| 2382228 | ecrin-mdr-crc

Microarray based metatranscriptomics in the human gut microbiome

Project description:Hundreds of microbial species were found to be transcriptionally active in the human gut microbiome based on the expression profiling of ca. 680.000 microbial genes As a part of the MetaHIT cohort 233 human stool samples were transcriptionally profiled using a custom made microarray that included probes for most prevalent microbial genes in the cohort as established by whole-genome sequencing of the same samples

2016-08-01 | E-GEOD-76590 | biostudies-arrayexpress

Evaluating in vitro culture medium of mouse gut microbiome

Project description:The mice stool samples were collected for culturing with different medium for understanding the role of different medium component on the microbiome.

2018-06-15 | PXD006808 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data